Tom Spurling – Executive Director – Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.
Copyright 2023 – Finance News Network
Source: Finance News Network
09 March 2023 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses drivers of revenue growth, the roadmap for the company's three SaaS solutions, onshoring GreenOrbit operations and outlook for the second half.
Read More09 Mar 2023 - Sequoia Financial Group Limited (ASX:SEQ) CEO and Managing Director Garry Crole discusses the 80 per cent sale of Morrison Securities to New Quantum.
Read More03 Nov 2023 - Vital Metals (ASX:VML) Chairman Richard Crookes shares exclusive insights on Nechalacho, Rare Earth projects, and the company's strategic partnerships, offering a compelling overview of their journey and future prospects.
Read More07 Mar 2023 - Eureka Group Holdings Limited (ASX:EGH) CEO Cameron Taylor provides an overview of the company, discussing positioning in the industry, strategy, the new development in Brassall, Queensland, government assistance and growth opportunities.
Read More22 Mar 2022 - Magnetite Mines Limited (ASX:MGT) Technical Director Mark Eames discusses the business case for further expansion of the Razorback Iron Ore Project in South Australia from three million tonnes per annum to seven million tonnes per annum.
Read More24 May 2021 - QEM Limited (ASX:QEM) Managing Director Gavin Loyden provides an update on the company's flagship 100%-owned Julia Creek vanadium and oil shale project in North Queensland.
Read More21 Feb 2024 - Lithium Universe Limited (ASX:LU7) CEO Alex Hanly discusses progress towards construction of a lithium refinery.
Read More08 Jul 2021 - ImpediMed Limited (ASX:IPD) CEO and Managing Director Richard Carreon discusses the company's bioimpedance spectroscopy platform SOZO, which is particularly targeted at noninvasive clinical assessment and monitoring of fluid status and tissue composition in the treatment of secondary lymphoedema, heart failure and renal failure.
Read More31 May 2023 - Ron Mitchell, Managing Director of Global Lithium Resources Limited (ASX:GL1), which owns two of the 14 lithium resources in Australia, discusses the price of lithium and progress on the company's projects.
Read More24 Nov 2020 - Altech Chemicals Limited (ASX:ATC) Managing Director Iggy Tan provides an update on construction of the company's high purity alumina (HPA) processing plant in Malaysia, its funding plans for the next phase of construction, growing HPA applications and plans for a second HPA plant in Saxony, Germany.
Read More
